1. Home
  2. ESQ vs IVA Comparison

ESQ vs IVA Comparison

Compare ESQ & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$118.47

Market Cap

941.0M

Sector

Finance

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$3.41

Market Cap

883.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESQ
IVA
Founded
2006
2011
Country
United States
France
Employees
N/A
77
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
941.0M
883.8M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
ESQ
IVA
Price
$118.47
$3.41
Analyst Decision
Buy
Strong Buy
Analyst Count
3
10
Target Price
$120.33
$16.20
AVG Volume (30 Days)
97.6K
1.1M
Earning Date
04-23-2026
03-30-2026
Dividend Yield
0.76%
N/A
EPS Growth
14.20
N/A
EPS
1.40
N/A
Revenue
N/A
N/A
Revenue This Year
$35.15
N/A
Revenue Next Year
$39.09
$751.20
P/E Ratio
$82.97
N/A
Revenue Growth
N/A
N/A
52 Week Low
$90.57
$2.94
52 Week High
$119.86
$7.98

Technical Indicators

Market Signals
Indicator
ESQ
IVA
Relative Strength Index (RSI) 64.63 30.98
Support Level $102.57 N/A
Resistance Level $118.48 $4.67
Average True Range (ATR) 3.53 0.18
MACD 0.44 0.01
Stochastic Oscillator 88.50 10.27

Price Performance

Historical Comparison
ESQ
IVA

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based clinical-stage biopharmaceutical company focused on the development of oral small-molecule therapies for the treatment of MASH. The wholly-owned research and development facility and a team with expertise and experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging the expertise, the company is also advancing lanifibranor for the treatment of MASH and has a pipeline of earlier-stage therapeutic programs in oncology. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France.

Share on Social Networks: